Abstract
Effect of Strong P-gp and BCRP Inhibition, Using Cyclosporine and Quinidine as Probes, on the Pharmacokinetics of Oral Rimegepant 75 mg in Healthy Subjects (P2-2.001)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have